Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Recce Pharmaceuticals Ltd. ( (AU:RCE) ) has issued an announcement.
Recce Pharmaceuticals Ltd has announced the application for the quotation of 26,370,567 ordinary fully paid securities on the Australian Securities Exchange (ASX) as of June 10, 2025. This move is part of previously announced transactions and is expected to enhance the company’s market presence, potentially increasing its visibility and accessibility to investors, thereby supporting its strategic growth initiatives in the pharmaceutical sector.
More about Recce Pharmaceuticals Ltd.
Recce Pharmaceuticals Ltd is a company operating in the pharmaceutical industry, focusing on the development and commercialization of new classes of synthetic anti-infectives designed to address the urgent global health threat posed by antibiotic-resistant superbugs and emerging viral pathogens.
Average Trading Volume: 225,640
Technical Sentiment Signal: Sell
Current Market Cap: A$79.91M
See more insights into RCE stock on TipRanks’ Stock Analysis page.